Filing Details

Accession Number:
0001062993-16-012534
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-29 17:15:58
Reporting Period:
2016-11-29
Filing Date:
2016-11-29
Accepted Time:
2016-11-29 17:15:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875622 Biospecifics Technologies Corp BSTC Pharmaceutical Preparations (2834) 113054851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405128 Toby Wegman C/O Biospecifics Technologies Corp.,
35 Wilbur Street
Lynbrook NY 11563
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.001 Par Value Disposition 2016-11-29 10,000 $48.08 949,973 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
Footnotes
  1. The selling price of $48.0832 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.00 to $48.2501. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. These shares are held in trust on behalf of the reporting person and Mr. Thomas Wegman. The reporting person is the co-trustee of the trust with Mr. Thomas Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.